|4Dec 7, 4:30 PM ET

AGIOS PHARMACEUTICALS INC 4

4 · AGIOS PHARMACEUTICALS INC · Filed Dec 7, 2015

Insider Transaction Report

Form 4
Period: 2015-12-03
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
  • Award

    Stock option (right to buy)

    2015-12-03+34,090239,112 total
    Exercise: $9.05Exp: 2023-04-29Common stock (34,090 underlying)
Footnotes (1)
  • [F1]This option was originally granted on April 30, 2013 for the purchase of 68,181 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to an additional 50% upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of the option as to 34,090 shares. The second performance milestone has not yet been met.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION